Download PDF
Thromb Haemost 2001; 85(04): 743
DOI: 10.1055/s-0037-1615662
Letters to the Editor
Schattauer GmbH

The Blue Toe Syndrome during Oral Anticoagulant Therapy with Acenocoumarol

M.A. Fernández
1   Unit of Anticoagulant Therapy, Department of Clinical Pathology, Unversity Hospital “La Fe”, Department of Dermaatology, General Hospital Valencia, Spain
,
R. Andreu
1   Unit of Anticoagulant Therapy, Department of Clinical Pathology, Unversity Hospital “La Fe”, Department of Dermaatology, General Hospital Valencia, Spain
,
J. M. Fortea
1   Unit of Anticoagulant Therapy, Department of Clinical Pathology, Unversity Hospital “La Fe”, Department of Dermaatology, General Hospital Valencia, Spain
,
J. Aznar
1   Unit of Anticoagulant Therapy, Department of Clinical Pathology, Unversity Hospital “La Fe”, Department of Dermaatology, General Hospital Valencia, Spain
› Author Affiliations
Further Information

Publication History

Received 21 September 2001

Accepted after revision 30 November 2000

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Karmody AM, Powers SR, Monaco VJ, Leather RP. “Blue toe” syndrome: an indication for limb salvage surgery. Arch Surg 1976; 111: 1263-8.
    CrossrefPubMedGoogle Scholar
  • 2 Feder W, Auerbach R. “Purple toes”: an uncommon sequela of oral coumarin drug therapy. Ann Intern Med 1961; 55: 91-7.
    PubMedGoogle Scholar
  • 3 O’Keeffe ST, Woods BO, Breslin DJ, Tsapatsaris NP. Blue toe syndrome. Arch Intern Med 1992; 152: 2197-202.
    CrossrefPubMedGoogle Scholar
  • 4 Sallah S, Thomas DP, Robers HR. Warfarin and Heparin-Induced Skin Necrosis and the Purple Toe Sydrome: Infrequent Complications of Anticoagulant Treatment. Thromb Haemost 1997; 78: 785-90.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Brewer ML, Kinnison ML, Perler BA, White RI. Blue Toe Syndrome: Treatment with Anticoagulants and Delayed Percutaneous Transluminal Angioplasty. Radiology 1988; 166: 31-6.
    CrossrefPubMedGoogle Scholar